-+ 0.00%
-+ 0.00%
-+ 0.00%

COEPTIS THERAPEUTICS ANNOUNCES PHASE 1 DATA ON DVX201 FOR COVID-19 TREATMENT HAS BEEN ACCEPTED FOR PUBLICATION IN MOLECULAR THERAPY METHODS AND CLINICAL DEVELOPMENT

Reuters·11/07/2024 13:07:07

Please log in to view news